The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index.
Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition
Open accessAbstract
The contributing effect of cerebrovascular pathology in Alzheimer's disease (AD) has become increasingly appreciated. Recent evidence suggests that amyloid-β peptide (Aβ), the same peptide found in neuritic plaques of AD, may play a role via its vasoactive properties. Several studies have examined young Tg2576 mice expressing mutant amyloid precursor protein (APP) and having elevated levels of soluble Aβ but no cerebral amyloid angiopathy (CAA). These studies suggest but do not prove that soluble Aβ can significantly impair the cerebral circulation. Other studies examining older Tg2576 mice having extensive CAA found even greater cerebrovascular dysfunction, suggesting that CAA is likely to further impair vascular function. Herein, we examined vasodilatory responses in young and older Tg2576 mice to further assess the roles of soluble and insoluble Aβ on vessel function. We found that (1) vascular impairment was present in both young and older Tg2576 mice; (2) a strong correlation between CAA severity and vessel reactivity exists; (3) a surprisingly small amount of CAA led to marked reduction or complete loss of vessel function; 4) CAA-induced vasomotor impairment resulted from dysfunction rather than loss or disruption of vascular smooth muscle cells; and 5) acute depletion of Aβ improved vessel function in young and to a lesser degree older Tg2576 mice. These results strongly suggest that both soluble and insoluble Aβ cause cerebrovascular dysfunction, that mechanisms other than Aβ-induced alteration in vessel integrity are responsible, and that anti-Aβ therapy may have beneficial vascular effects in addition to positive effects on parenchymal amyloid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Deposition of amyloid-β within microvessels is highly frequent in patients with Alzheimer’s disease dementia (Kalaria, 2016) and associated with reduced blood flow in transgenic mouse models (Han et al., 2008; Saito et al., 2017) and humans (Chung et al., 2009; Dumas et al., 2012).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Han et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“evidence for this possibility comes from animal models in which exogenously applied or genetically overexpressed Aβ production diminished vasodilation to pharmacological or physiological stimuli, even in the absence of vascular Aβ deposits.115,160,161”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Self-citationCerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 2×
“Consistent with previous reports (Hsiao et al., 1996; Kawarabayashi et al., 2001; Fryer et al., 2003), we found no parenchymal or vascular amyloid deposits in 6-month-old Tg2576 mice (Fig.”
ResultBrain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics
de la Torre, J. C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00683-0 · Cited by 834
Research works printed but not linked: 1
- 10.1172/JCI200523269 · DOI · Paper page
Cited by
Sorted by citations
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
Cerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
Emerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555
Deane, R., Bell, R. D., Sagare, A. P., & Zloković, B. V. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 559
Hawkes, C. A., Härtig, W., Kacza, J., Schliebs, R., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0801-7 · Cited by 365
Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides
Park, L., Uekawa, K., Garcia-Bonilla, L., Koizumi, K., Murphy, M., Pistik, R., Younkin, L., Younkin, S., Zhou, P., Carlson, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311054 · Cited by 259
Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248
Genetic mouse models of brain ageing and Alzheimer's disease
Bilkei‐Gorzó, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.009 · Cited by 253
Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies
Bien-Ly, N., Boswell, C. A., Jeet, S., Beach, T. G., Hoyte, K., Luk, W., Shihadeh, V., Ulufatu, S., Foreman, O., Lu, Y., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.036 · Cited by 198
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
Dumas, A. P., Dierksen, G. A., Gurol, M. E., Halpin, A., Martínez‐Ramírez, S., Schwab, K. M., Rosand, J. M., Viswanathan, A., Salat, D. H., Polimeni, J. R., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23566 · Cited by 182
Xiong, M., Jiang, H., Serrano, J. R., Gonzales, E. R., Wang, C., Gratuze, M., Hoyle, R., Bien-Ly, N., Silverman, A. P., Sullivan, P. M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7522 · Cited by 179
Self-citationAge-dependent rescue by simvastatin of Alzheimer’s disease cerebrovascular and memory deficits
Tong, X.-K., Lecrux, C., & Hamel, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-12.2012 · Cited by 160
Neurovascular function in Alzheimer's disease patients and experimental models
Nicolakakis, N., & Hamel, E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.43 · Cited by 156
Dorr, A. E., Sahota, B., Chinta, L. V., Brown, M. E., Lai, A. Y., Ma, K., Hawkes, C. A., McLaurin, J., & Stefanovic, B. (2012) · Brain · doi:10.1093/brain/aws243 · Cited by 156
Scuteri, A., Nilsson, P. M., Tzourio, C., Redon, J., & Laurent, S. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347cc17 · Cited by 151
Outcome markers for clinical trials in cerebral amyloid angiopathy
Greenberg, S. M., Salman, R. A., Biessels, G. J., van Buchem, M. A., Cordonnier, C., Lee, J., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M. W., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70003-1 · Cited by 150
Ischemic brain injury in cerebral amyloid angiopathy
Reijmer, Y. D., van Veluw, S. J., & Greenberg, S. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.88 · Cited by 145
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 146
Han, B. H., Zhou, M.-L., Johnson, A. W., Singh, I., Liao, F., Vellimana, A. K., Nelson, J. W., Milner, E., Cirrito, J. R., Basak, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414930112 · Cited by 131
Self-citationHuang, D., Li, S., Dhaka, A. K., Story, G. M., & Cao, Y. Q. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-66 · Cited by 129
Cerebrovascular disease, beta-amyloid, and cognition in aging
Marchant, N. L., Reed, B. R., DeCarli, C. S., Madison, C. M., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.001 · Cited by 127
Impaired Cerebral Autoregulation and Vasomotor Reactivity in Sporadic Alzheimer’s Disease
den Abeelen, A. S. S. M.-V., Lagró, J., van Beek, A. H. E. A., & Claassen, J. A. H. R. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131119234845 · Cited by 114
Saito, S., Yamamoto, Y., Maki, T., Hattori, Y., Ito, H., Mizuno, K., Harada-Shiba, M., Kalaria, R. N., Fukushima, M., Takahashi, R., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0429-5 · Cited by 110
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110
β‐Secretase inhibitor GRL‐8234 rescues age‐related cognitive decline in APP transgenic mice
Chang, W., Huang, X., Downs, D., Cirrito, J. R., Koelsch, G., Holtzman, D. M., Ghosh, A. K., & Tang, J. (2010) · The FASEB Journal · doi:10.1096/fj.10-167213 · Cited by 110
Self-citationEarly neurovascular dysfunction in a transgenic rat model of Alzheimer’s disease
Joo, I. L., Lai, A. Y., Bazzigaluppi, P., Koletar, M. M., Dorr, A. E., Brown, M. E., Thomason, L. A. M., Sled, J. G., McLaurin, J., & Stefanovic, B. (2017) · Scientific Reports · doi:10.1038/srep46427 · Cited by 101
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104
Torres, M., Jiménez, S., Sanchez-Varo, R. M., Navarro, V., Trujillo‐Estrada, L., Sánchez‐Mejías, E., Carmona, I., Dávila, J. C., Vizuete, M., Gutiérrez, A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-59 · Cited by 103
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Marco, L. Y. D., Farkas, E., Martin, C. J., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142976 · Cited by 94
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer’s Disease of humans and mice
Cacciottolo, M., Christensen, A., Moser, A., Liu, J., Pike, C., Smith, C., LaDu, M., Sullivan, P., Morgan, T., Dolzhenko, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.010 · Cited by 93
van Opstal, A. M., van Rooden, S., van Harten, T. W., Ghariq, E., Labadie, G., Fotiadis, P., Gurol, M. E., Terwindt, G. M., Wermer, M. J. H., van Buchem, M. A., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30346-5 · Cited by 92
Oxidative stress: A target to treat Alzheimer's disease and stroke
Briyal, S., Ranjan, A. K., & Gulati, A. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105509 · Cited by 88
Cerebral amyloid angiopathy as a cause of neurodegeneration
Smith, E. E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14157 · Cited by 86
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 87
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Wan, W., Chen, H., & Li, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.825258 · Cited by 83
Duncombe, J., Lennen, R. J., Jansen, M. A., Marshall, I., Wardlaw, J. M., & Horsburgh, K. J. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12375 · Cited by 85
Oscillations in cerebral blood flow and cortical oxygenation in Alzheimer's disease
van Beek, A. H. E. A., Lagró, J., Olde-Rikkert, M. G. M., Zhang, R., & Claassen, J. A. H. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.016 · Cited by 77
Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells
Dietrich, H. H., Xiang, C., Han, B. H., Zipfel, G. J., & Holtzman, D. M. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-15 · Cited by 81
Self-citationSildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer’s Disease
Sheng, M., Lu, H., Liu, P., Li, Y., Ravi, H., Peng, S., Diaz-Arrastia, R. R., Devous, M. D., & Womack, K. B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161006 · Cited by 75
Papadopoulos, P., Rosa‐Neto, P., Rochford, J. M., & Hamel, É. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068612 · Cited by 75
Bandara, N., Sharma, A. K., Krieger, S., Schultz, J. W., Han, B. H., Rogers, B. E., & Mirica, L. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05937 · Cited by 82
Self-citationMore than just summed neuronal activity: how multiple cell types shape the BOLD response
Howarth, C., Mishra, A., & Hall, C. N. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0630 · Cited by 87
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saitô, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 77
Disentangling the effects of age and APOE on neuropathology and late life cognitive decline
Yu, L., Boyle, P. A., Leurgans, S., Schneider, J. A., & Bennett, D. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.074 · Cited by 71
Lacoste, B., Tong, X.-K., Lahjouji, K., Couture, R., & Hamel, E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-57 · Cited by 73
Animal models of cerebral amyloid angiopathy
Jäkel, L., Nostrand, W. E. V., Nicoll, J. A. R., Werring, D. J., & Verbeek, M. M. (2017) · Clinical Science · doi:10.1042/cs20170033 · Cited by 71
Bales, K. R., O’Neill, S. M., Pozdnyakov, N., Pan, F., Caouette, D., Pi, Y., Wood, K. M., Volfson, D., Cirrito, J. R., Han, B.-H., et al. (2016) · Brain · doi:10.1093/brain/awv313 · Cited by 68
Self-citationWhite Matter Hyperintensities as Early and Independent Predictors of Alzheimer's Disease Risk
Mortamais, M., Artéro, S., & Ritchie, K. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141473 · Cited by 69
Wahane, S., Hellbach, N., Prentzell, M. T., Weise, S. C., Vezzali, R., Kreutz, C., Timmer, J., KRIEGLSTEIN, K. G., Thedieck, K., & Vogel, T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12718 · Cited by 63
The role of fMRI in drug development
Carmichael, O. T., Schwarz, A. J., Chatham, C. H., Scott, D., Turner, J. A., Upadhyay, J., Coimbra, A., Goodman, J. A., Baumgartner, R., English, B. A., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.012 · Cited by 60
Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease
Hébert, F., Grand’Maison, M., Ho, M., Lerch, J. P., Hamel, É., & Bedell, B. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.022 · Cited by 62
Han, B. W., Zhou, M., Vellimana, A. K., Milner, E., Kim, D. H., Greenberg, J. K., Chu, W., Mach, R. H., & Zipfel, G. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-86 · Cited by 55
Self-citationOngali, B., Nicolakakis, N., Lecrux, C., Aboulkassim, T., Rosa‐Neto, P., Papadopoulos, P., Tong, X., & Hamel, É. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100339 · Cited by 58
Hiltunen, M. O., van Groen, T., & Jolkkonen, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1154 · Cited by 62
Kitazume, S., Yoshihisa, A., Yamaki, T., Oikawa, M., Tachida, Y., Ogawa, K., Imamaki, R., Hagiwara, Y., Kinoshita, N., Takeishi, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398578 · Cited by 58
Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy
van Veluw, S. J., Reijmer, Y. D., van der Kouwe, A. J. W., Charidimou, A., Riley, G. A., Leemans, A., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2019) · Neurology · doi:10.1212/wnl.0000000000007005 · Cited by 58
Park, L., Zhou, P., Koizumi, K., Jamal, S. E., Previti, M. L., Nostrand, W. E. V., Carlson, G. A., & Iadecola, C. (2012) · Stroke · doi:10.1161/strokeaha.112.670976 · Cited by 55
Ni, R., Rudin, M., & Klohs, J. (2018) · Photoacoustics · doi:10.1016/j.pacs.2018.04.001 · Cited by 53
Allele-specific RNAi Mitigates Phenotypic Progression in a Transgenic Model of Alzheimer's Disease
Rodríguez-Lebrón, E., Gouvion, C. M., Moore, S. A., Davidson, B. L., & Paulson, H. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.123 · Cited by 54
Liu, R., Zhang, T., Zhou, D., Bai, X., Zhou, W., Huang, C., Song, J.-K., Meng, F.-R., Wu, C., Li, L., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.018 · Cited by 54
HIF‐1α Mediates Isoflurane‐Induced Vascular Protection in Subarachnoid Hemorrhage
Milner, E., Johnson, A. W., Nelson, J. W., Harries, M. D., Gidday, J. M., Han, B. H., & Zipfel, G. J. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.170 · Cited by 52
Self-citationTanaka, M., Saitô, S., Inoue, T., Satoh‐Asahara, N., & Ihara, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092139 · Cited by 48
Choi, E. Y., Kang, S. S., Lee, S. K., & Han, B. H. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.113 · Cited by 45
Self-citationKara, F., van Dongen, E. S., Schliebs, R., van Buchem, M. A., de Groot, H. J. M., & Alia, A. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.055 · Cited by 44
Liu, R., Li, J.-Z., Song, J.-K., Sun, J., Li, Y., Zhou, S., Zhang, T., & Du, G. (2014) · BioMed Research International · doi:10.1155/2014/470393 · Cited by 43
Xiong, M., Wang, C., Gratuze, M., Saadi, F., Bao, X., Bosch, M. E., Lee, C., Jiang, H., Serrano, J. R., Gonzales, E. R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00610-x · Cited by 41
Self-citationNeurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy
Hamel, É., Royea, J., Ongali, B., & Tong, X. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0285-4 · Cited by 43
Soto-Rojas, L. O., Campa-Córdoba, B. B., Harrington, C. R., Salas‐Casas, A., Hernándes‐Alejandro, M., Villanueva‐Fierro, I., Bravo-Muñoz, M., Garcés‐Ramírez, L., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073654 · Cited by 41
Hawkes, C. A., Michalski, D., Anders, R. M., Nissel, S., Grosche, J., Bechmann, I., Carare, R. O., & Härtig, W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.020 · Cited by 39
Therapeutic Modulation of Cerebral Microhemorrhage in a Mouse Model of Cerebral Amyloid Angiopathy
Fisher, M., Vasilevko, V., Passos, G. F., Ventura, C. M., Quiring, D., & Cribbs, D. H. (2011) · Stroke · doi:10.1161/strokeaha.111.626655 · Cited by 38
Tayara, N. E. T. E., Delatour, B., Volk, A., & Dhénain, M. (2010) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-009-0194-y · Cited by 36
Briyal, S., Shepard, C., & Gulati, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.008 · Cited by 35
van Beek, A. H. E. A., Sijbesma, J. C., Jansen, R. W. M. M., Rikkert, M. G. M. O., & Claassen, J. A. H. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100288 · Cited by 35
Hamel, É. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000177 · Cited by 34
Characterization of a mouse model of headache
Huang, D., Ren, L. Y., Qiu, C.-S., Liu, P., Peterson, J., Yanagawa, Y., & Cao, Y. Q. (2016) · Pain · doi:10.1097/j.pain.0000000000000578 · Cited by 34
Nicolakakis, N., Aboulkassim, T., Aliaga, A., Tong, X., Rosa‐Neto, P., & Hamel, É. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.78 · Cited by 34
Zhao, L., Hou, L., Sun, H., Yan, X., Sun, X., Li, J., Bian, Y., Chu, Y., & Liu, Q. (2011) · Molecules · doi:10.3390/molecules16054005 · Cited by 33
Perivascular macrophages in the CNS : From health to neurovascular diseases
Li, Z., Guo, Y., Zhai, X., Zhang, Y., Chen, W., Zhu, Z., Xuan, W., & Li, P. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13954 · Cited by 36
Milner, E., Zhou, M., Johnson, A. W., Vellimana, A. K., Greenberg, J. K., Holtzman, D. M., Han, B. H., & Zipfel, G. J. (2014) · Stroke · doi:10.1161/strokeaha.114.006078 · Cited by 33
Self-citationZeller, J. B. M., Katzorke, A., Müller, L. D., Breunig, J., Haeussinger, F. B., Deckert, J., Warrings, B., Lauer, M., Polak, T. T., & Herrmann, M. J. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9827-y · Cited by 32
CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers
Ahmad, S., Milan, M. D. C., Hansson, O., Demirkan, A., Agustin, R., Sáez, M. E., Giagtzoglou, N., Cabrera-Socorro, A., Bakker, M. H. M., Ramirez, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65038-5 · Cited by 31
Reynolds, M. R., Singh, I., Azad, T. D., Holmes, B. B., Verghese, P. B., Dietrich, H. H., Diamond, M. I., Bu, G., Han, B. H., & Zipfel, G. J. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0073-8 · Cited by 32
Self-citationApolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice
Finch, C. E., & Shams, S. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.07.002 · Cited by 29
Jiang-Ran, L. I., Sun, M., Ping, Q. N., Chen, X., Qi, J., & Han, D. (2010) · Chinese Journal of Natural Medicines · doi:10.3724/sp.j.1009.2010.00223 · Cited by 28
Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease
Bagi, Z. A., Kroenke, C. D., Fopiano, K. A., Tian, Y., Filosa, J. A., Sherman, L. S., Larson, E. B., Keene, C. D., Degener-O’Brien, K., Adeniyi, P. A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00585-5 · Cited by 27
Liu, R., Zhang, T.-T., Wu, C.-X., Lan, X., & Du, G.-H. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.05.015 · Cited by 27
Babiloni, C., Vecchio, F., Altavilla, R., Tibuzzi, F., Lizio, R., Altamura, C., Palazzo, P., Maggio, P., Ursini, F., Ercolani, M., et al. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.10.002 · Cited by 24
β -Secretases, Alzheimer’s Disease, and Down Syndrome
Webb, R. L., & Murphy, M. P. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/362839 · Cited by 26
H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?
Salmina, A. B., Komleva, Y. K., Szijártó, I. A., Gorina, Y. V., Lopatina, O. L., Gertsog, G. E., Filipović, M. R., & Gollasch, M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00361 · Cited by 24
Sharp, P. S., Ameen-Ali, K. E., Boorman, L., Harris, S., Wharton, S. B., Howarth, C., Shabir, O., Redgrave, P., & Berwick, J. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19890830 · Cited by 25
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 21
Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer’s Disease Pathology
Ulrich, J. D., Huynh, T. V., & Holtzman, D. M. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.008 · Cited by 25
Self-citationAmyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation
Hald, E. S., Timm, C. D., & Alford, P. W. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4034560 · Cited by 21
Amentoflavone Promotes Cellular Uptake and Degradation of Amyloid-Beta in Neuronal Cells
Han, B. H., Cofell, B., Everhart, E., Humpal, C., Kang, S.-S., Lee, S. K., & Kim‐Han, J. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115885 · Cited by 20
Self-citationPerucho, J., Casarejos, M. J., Rubio, I., Rodríguez‐Navarro, J. A., Gómez, A., Ampuero, I., Rodal, I., Solano, R. M., Carro, E., de Yébenes, J. G., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.029 · Cited by 16
Jäkel, L., Biemans, E. A. L. M., Klijn, C. J. M., Kuiperij, H. B., & Verbeek, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01873-x · Cited by 15
Metadata
- Authors
- Han, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-12-10
- Volume
- 28
- Issue
- 50
- Pages
- 13542-13550
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2626633
- OpenAlex
- W2032210346
- Cited by
- 138
- References
- 63
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 2 · 2023: 10 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 12 · 2016: 10 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Eli Lilly and Company
- Congress of Neurological Surgeons
- National Institutes of Health (NS057105)
- National Institute of Neurological Disorders and Stroke (R25NS090978, P30NS057105, NS057105, P01NS032636, K08NS053899, NS-032636, NS053899)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- cerebrovascular dysfunction, amyloid-beta, cerebral amyloid angiopathy, Alzheimer's disease, Tg2576 mice, amyloid precursor protein, soluble amyloid-beta, gamma-secretase inhibition, vasodilation, vascular smooth muscle cells, anti-amyloid therapy
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cerebrovascular Circulation, Mice, Transgenic, Muscle, Smooth, Vascular, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Cerebral Amyloid Angiopathy, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
